As of 2025-11-06, the Relative Valuation of Sorrento Therapeutics Inc (SRNE) is (23.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 USD, the upside of Sorrento Therapeutics Inc based on Relative Valuation is -262859.6%.
The range of the Relative Valuation is (17.96) - (30.08) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 21.7x | 15.3x |
| Forward P/E multiples | 11.5x - 19.4x | 15.2x |
| Fair Price | (17.96) - (30.08) | (23.65) |
| Upside | -199625.0% - -334364.6% | -262859.6% |
| Date | P/E |
| 2025-11-04 | -0.01 |
| 2025-11-03 | -0.01 |
| 2025-10-31 | -0.01 |
| 2025-10-30 | -0.00 |
| 2025-10-29 | -0.00 |
| 2025-10-28 | -0.00 |
| 2025-10-27 | -0.00 |
| 2025-10-24 | -0.00 |
| 2025-10-23 | -0.00 |
| 2025-10-22 | -0.00 |
| 2025-10-21 | -0.01 |
| 2025-10-20 | -0.01 |
| 2025-10-17 | -0.00 |
| 2025-10-16 | -0.00 |
| 2025-10-15 | -0.00 |
| 2025-10-14 | -0.00 |
| 2025-10-13 | -0.00 |
| 2025-10-10 | -0.00 |
| 2025-10-09 | -0.00 |
| 2025-10-08 | -0.00 |
| 2025-10-07 | -0.00 |
| 2025-10-06 | -0.00 |
| 2025-10-03 | -0.00 |
| 2025-10-02 | -0.00 |
| 2025-10-01 | -0.00 |
| 2025-09-30 | -0.00 |
| 2025-09-29 | -0.00 |
| 2025-09-26 | -0.00 |
| 2025-09-25 | -0.00 |
| 2025-09-24 | -0.00 |
| 2025-09-23 | -0.00 |
| 2025-09-22 | -0.00 |
| 2025-09-19 | -0.00 |
| 2025-09-18 | -0.00 |
| 2025-09-17 | -0.00 |
| 2025-09-16 | -0.00 |
| 2025-09-15 | -0.00 |
| 2025-09-12 | -0.00 |
| 2025-09-11 | -0.00 |
| 2025-09-10 | -0.00 |
| 2025-09-09 | -0.00 |
| 2025-09-08 | -0.00 |
| 2025-09-05 | -0.00 |
| 2025-09-04 | -0.00 |
| 2025-09-03 | -0.00 |
| 2025-09-02 | -0.00 |
| 2025-08-29 | -0.00 |
| 2025-08-28 | -0.00 |
| 2025-08-27 | -0.00 |
| 2025-08-26 | -0.00 |